Literature DB >> 679210

11beta-Methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17beta-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues.

J P Raynaud, P M Martin, M M Bouton, T Ojasoo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679210

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells.

Authors:  A Aydiner; M Ridvanogullari; D Anil; E Topuz; R Nurten; R Disci
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  [Ultrastructural localization of estradiol and moxestrol in the gonadotropic cells of rat by immunocytology after cryo-ultramicrotomy: evidence for hormonal specificity (author's transl)].

Authors:  G Morel; J P Raynaud; P M Dubois
Journal:  Experientia       Date:  1981-01-15

3.  Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.

Authors:  R Poulin; Y Merand; D Poirier; C Levesque; J M Dufour; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

4.  Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases.

Authors:  H Magdelenat; B F Pertuiset; M Poisson; P M Martin; J Philippon; B Pertuiset; A Buge
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  Steroid hormone receptors in human meningiomas, gliomas and brain metastases.

Authors:  M Poisson; B F Pertuiset; J J Hauw; J Philippon; A Buge; M Moguilewsky; D Philibert
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

Review 6.  The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Authors:  John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2020-02-22       Impact factor: 2.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.